- High gross margin of 89.4%
- Low bankruptcy risk (Altman Z-Score: 6.62)
- Bullish trend confirmed on both short and long timeframes
Rhythm Pharmaceuticals Inc stock downgraded from Hold/Accumulate to Sell Candidate after Monday trading session
(Updated on Jun 08, 2026)
The Rhythm Pharmaceuticals Inc stock price fell by -0.550% on the last day (Monday, 8th Jun 2026) from $86.40 to $85.93. During the last trading day the stock fluctuated 2.62% from a day low at $84.88 to a day high of $87.10. The price has been going up and down for this period, and there has been a -2.18% loss for the last 2 weeks. Volume has increased on the last day by 74 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 466 thousand shares were bought and sold for approximately $40.00 million.
The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 2.38% during the next 3 months and, with a 90% probability hold a price between $79.43 and $99.72 at the end of this 3-month period.
RYTM Signals & Forecast
There are few to no technical positive signals at the moment. The Rhythm Pharmaceuticals Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $86.46 and $88.20. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, May 06, 2026, and so far it has fallen -11.06%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for Rhythm Pharmaceuticals Inc stock
Rhythm Pharmaceuticals Inc finds support from accumulated volume at $85.58 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.22 between high and low, or 2.62%. For the last week, the stock has had daily average volatility of 3.77%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (RYTM) For The Upcoming Trading Day Of Tuesday 9th
For the upcoming trading day on Tuesday, 9th we expect Rhythm Pharmaceuticals Inc to open at $85.97, and during the day (based on 14 day Average True Range), to move between $83.96 and $87.89, which gives a possible trading interval of +/-$3.92 (+/-4.67%) up or down from last closing price. If Rhythm Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 4.67% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $85.58 (0.40%) than the resistance at $86.97 (1.22%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Rhythm Pharmaceuticals Inc stock A Buy?
The Rhythm Pharmaceuticals Inc stock holds several negative signals and despite the positive trend, we believe Rhythm Pharmaceuticals Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.
Current score:
-2.303
Sell Candidate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on June 9, 2026 - $85.97 ( 0.0509%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
RYTM Performance
Trading levels for RYTM
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 88.19 | 2.64% |
| R2 | 87.34 | 1.65% |
| R1 | 86.82 | 1.04% |
| Price | 85.93 | |
| S1 | 85.12 | -0.94% |
| S2 | 84.60 | -1.55% |
| S3 | 83.75 | -2.53% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 92.31 | 7.43% |
| R2 | 87.45 | 1.77% |
| R1 | 86.97 | 1.22% |
| Price | 85.93 | |
| S1 | 85.58 | -0.402% |
| S2 | 84.62 | -1.52% |
| S3 | 75.82 | -11.76% |
FAQ
Click here for our free guide on how to buy Rhythm Pharmaceuticals Inc Stock.
Buy RYTM